Hemodynamic response to non-selective beta blockers despite lack of effects on heart rate and systemic blood pressure

被引:0
|
作者
Bota, S. [1 ]
Mandorfer, M. [1 ]
Ferlitsch, A. [1 ]
Peck-Radosavljevic, M. [1 ]
Reiberger, T. [1 ]
机构
[1] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P20
引用
收藏
页码:567 / 568
页数:2
相关论文
共 50 条
  • [1] HEMODYNAMIC RESPONSE TO NON-SELECTIVE BETA BLOCKERS DESPITE LACK OF EFFECTS ON HEART RATE AND SYSTEMIC BLOOD PRESSURE
    Bota, S.
    Mandorfer, M.
    Schwabl, P.
    Salzl, P.
    Ferlitsch, A.
    Peck-Radosavljevic, M.
    Reiberger, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S237 - S237
  • [2] Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis
    Tergast, Tammo L.
    Kimmann, Markus
    Laser, Hans
    Gerbel, Svetlana
    Manns, Michael P.
    Cornberg, Markus
    Maasoumy, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (06) : 696 - 706
  • [3] The predictive value of changes in heart rate and arterial pressure for hemodynamic response to non-selective betablockers
    Bota, Simona
    Schwabl, Philipp
    Mandorfer, Mattias
    Bucsics, Theresa
    Schwarzer, Remy
    Trauner, Michael
    Ferlitsch, Arnulf
    Peck-Radosavljevic, Markus
    Reiberger, Thomas
    HEPATOLOGY, 2015, 62 : 593A - 594A
  • [4] Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome
    Bota, S.
    Schwabl, P.
    Ferlitsch, A.
    Peck-Radosavljevic, M.
    Reiberger, T.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (17-18) : 568 - 568
  • [5] HEMODYNAMIC RESPONSE TO NON-SELECTIVE BETA-BLOCKERS IS NOT INFLUENCED BY THE PRESENCE OF METABOLIC SYNDROME
    Bota, S.
    Schwabl, P.
    Mandorfer, M.
    Salzl, P.
    Schwarzer, R.
    Ferlitsch, A.
    Trauner, M.
    Peck-Radosavljevic, M.
    Reiberger, T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S383 - S384
  • [6] Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome
    Bota, Simona
    Schwabl, Philipp
    Mandorfer, Mattias
    Salzl, Petra
    Ferlitsch, Arnulf
    Trauner, Michael
    Peck-Radosavljevic, Markus
    Reiberger, Thomas
    HEPATOLOGY, 2014, 60 : 1196A - 1197A
  • [7] A Hemodynamic Response to Treatment With Non-Selective Beta-Blockers Protects Against Worsening of Thrombocytopenia in Cirrhosis
    Qamar, Amir A.
    Grace, Norman D.
    Groszmann, Roberto J.
    Garcia-Tsao, Guadalupe
    Bosch, Jaime
    Burroughs, Andrew K.
    Iskandar, Heba
    Maurer, Rie
    Planas, Ramon
    Escorsell, Angels
    Garcia-Pagan, Juan Carlos
    Patch, David
    Matloff, Daniel S.
    Makuch, Robert
    GASTROENTEROLOGY, 2010, 138 (05) : S817 - S817
  • [8] Editorial: pressure to close the therapeutic window of non-selective beta blockers?
    Mandorfer, Mattias
    Reiberger, Thomas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (08) : 957 - 958
  • [9] Beneficial effects of non-selective beta blockers on mechanical and electrical activities of diabetic rat heart
    Tuncay, Erkan
    Seymen, Aytac
    Turan, Belma
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (04) : 775 - 775
  • [10] Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis
    Gimenez, Paula
    Garcia-Martinez, Irma
    Frances, Ruben
    Gonzalez-Navajas, Jose M.
    Mauri, Montserrat
    Alfayate, Rocio
    Almenara, Susana
    Miralles, Cayetano
    Palazon, Jose M.
    Carnicer, Fernando
    Pascual, Sonia
    Such, Jose
    Horga, Jose F.
    Zapater, Pedro
    LIVER INTERNATIONAL, 2018, 38 (12) : 2219 - 2227